Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amylyx Pharmaceuticals (AMLX) Inventory Average (2022 - 2023)

Historic Inventory Average for Amylyx Pharmaceuticals (AMLX) over the last 2 years, with Q4 2023 value amounting to $35.3 million.

  • Amylyx Pharmaceuticals' Inventory Average rose 58425.28% to $35.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $35.3 million, marking a year-over-year increase of 58425.28%. This contributed to the annual value of $24.0 million for FY2023, which is N/A changed from last year.
  • As of Q4 2023, Amylyx Pharmaceuticals' Inventory Average stood at $35.3 million, which was up 58425.28% from $28.6 million recorded in Q3 2023.
  • Amylyx Pharmaceuticals' 5-year Inventory Average high stood at $35.3 million for Q4 2023, and its period low was $5.2 million during Q4 2022.